Skip to main content

Pharmacotherapy of Trigeminal Neuralgia

  • Chapter
  • First Online:
Handbook of Trigeminal Neuralgia
  • 1217 Accesses

Abstract

Trigeminal neuralgia (TGN) is a disorder characterized by brief but severe electric shock-like pain, which is abrupt in onset and termination, and is limited to the distribution of one or more divisions of the trigeminal nerve [1]. It is further sub-classified into classical (CTN) and symptomatic forms (STN), the latter is associated with a demonstrable lesion on imaging apart from a vascular loop [1]. STN should be suspected when a patient presents with bilateral symptoms or concomitant trigeminal sensory loss. The distinction is important as the treatment for both differs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. International Headache Society. The international classification of headache disorders: 2nd Edition. Cephalalgia. 2004;24(Suppl 1):9–160.

    Google Scholar 

  2. Obermann M. Treatment options in trigeminal neuralgia. Ther Adv Neurol Disord. 2010;3:107–15.

    Article  CAS  Google Scholar 

  3. Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbamazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1966;29:265–7.

    Article  CAS  Google Scholar 

  4. Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Arch Neurol. 1968;19:129–36.

    Article  CAS  Google Scholar 

  5. Nicol CF. A four year double blind study of tegretol in facial pain. Headache. 1969;9:54–7.

    Article  CAS  Google Scholar 

  6. Rockcliff BW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol. 1996;15:129–36.

    Article  Google Scholar 

  7. Kutluay E, McCague K, D’Souza J, Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav. 2003;4:175–80.

    Article  Google Scholar 

  8. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 1997;73:223–30.

    Article  CAS  Google Scholar 

  9. Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol. 1984;15:240–4.

    Article  CAS  Google Scholar 

  10. Sindrup SH, Jensen TS. Pharmacotherapy of trigeminal neuralgia. Clin J Pain. 2002;18:22–7.

    Article  Google Scholar 

  11. Lemos L, Flores S, Oliveira P, Almeida A. Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. Clin J Pain. 2008;24:64–75.

    Article  Google Scholar 

  12. Obermann M, Yoon MS, Sensen K, Maschke M, Diener HC, Katsarava Z. Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia. 2008;28:174–81.

    Article  CAS  Google Scholar 

  13. Domingues RB, Kuster GW, Aquino CC. Treatment of trigeminal neuralgia with low doses of topiramate. Arq Neuropsiquiatr. 2007;65:792–4.

    Article  Google Scholar 

  14. Jorns TP, Johnston A, Zakrzewska JM. Pilot study to evaluate the efficacy and tolerability of levetiracetam in treatment of patients with trigeminal neuralgia. Eur J Neurol. 2009;16:740–4.

    Article  CAS  Google Scholar 

  15. Desai N, Shah K, Gandhi I. Baclofen sodium valproate combination in carbamazepine resistant trigeminal neuralgia: a double blind clinical trial. Cephalalgia. 1991;II(Suppl):321–2.

    Article  Google Scholar 

  16. Carasso RL, Yehuda S, Streifler M. Clomipramine and amitriptyline in the treatment of severe pain. Int J Neurosci. 1979;9:191–4.

    Article  CAS  Google Scholar 

  17. Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K, Nurmikko T, Zakrzewska JM, American Academy of Neurology Society, European Federation of Neurological Society. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008;15:1013–28.

    Article  CAS  Google Scholar 

  18. William P. Cheshire. Trigeminal neuralgia: a guide to drug choice. CNS Drugs. 1997;7:98–110.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Agarwal, A., Tripathi, M. (2019). Pharmacotherapy of Trigeminal Neuralgia. In: Rath, G. (eds) Handbook of Trigeminal Neuralgia. Springer, Singapore. https://doi.org/10.1007/978-981-13-2333-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-2333-1_8

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-2332-4

  • Online ISBN: 978-981-13-2333-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics